- abnormal T cell activation / MGI
- decreased inflammatory response / MGI
- abnormal T cell differentiation / MGI
- increased double-positive T cell number / MGI
- decreased T cell proliferation / MGI
- decreased susceptibility to type IV hypersensitivity reaction / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- decreased CD8-positive, alpha-beta T cell number / MGI
- abnormal cytokine level / MGI
B6.129P2-Mmp19tm1Rase/Ph
| Status | Available to order |
| EMMA ID | EM:06786 |
| Citation information | RRID:IMSR_EM:06786 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | B6.129P2-Mmp19tm1Rase/Ph |
| Alternative name | B6.MMP19 |
| Strain type | Targeted Mutant Strains : Knock-out |
| Allele/Transgene symbol | Mmp19tm1Rase |
| Gene/Transgene symbol | Mmp19 |
Information from provider
| Provider | Radislav Sedlacek |
| Provider affiliation | Department of Transgenic Models of Diseases, Institute of Molecular Genetics |
| Genetic information | A targeting construct based on pPNT vector was generated by replacement of 1088 bp region of MMP19 gene spanning the end of exon 3 and the whole exon 4 encoding the catalytic domain by the neomycin resistance cassette. |
| Phenotypic information | a) MMP19-/- mice show reduced inflammatory reactions in the skin. Immature knockout mice have delayed development of thymocyte. b) MMP-19-deficiency reduces the extent of hepatocellular injury and leads to faster recovery from liver fibrosis. |
| Breeding history | The strain is kept on C57BL/6NCrl background and backcrossed more than 20 generations. wt x het, het x het and ko x ko matings are currently done. |
| References |
|
| Homozygous fertile | yes |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | no |
Information from EMMA
| Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
| Animals used for archiving | homozygous males, wild-type females |
| Stage of embryos | 2-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Familial cavitary optic disc anomaly / Orphanet_464760
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- abnormal T cell activation / MGI
- decreased inflammatory response / MGI
- abnormal T cell differentiation / MGI
- decreased incidence of tumors by chemical induction / MGI
- increased double-positive T cell number / MGI
- decreased T cell proliferation / MGI
- abnormal fat pad morphology / MGI
- decreased susceptibility to type IV hypersensitivity reaction / MGI
- increased susceptibility to diet-induced obesity / MGI
- increased fat cell size / MGI
- decreased CD4-positive, alpha beta T cell number / MGI
- decreased CD8-positive, alpha-beta T cell number / MGI
- abnormal cytokine level / MGI
- increased gonadal fat pad weight / MGI
Literature references
- MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses.;Beck Inken M, Rückert René, Brandt Katja, Mueller Markus S, Sadowski Thorsten, Brauer Rena, Schirmacher Peter, Mentlein Rolf, Sedlacek Radislav, ;2008;PloS one;3;e2343; 18523579
- Hepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosis.;Jirouskova Marketa, Zbodakova Olga, Gregor Martin, Chalupsky Karel, Sarnova Lenka, Hajduch Marian, Ehrmann Jiri, Jirkovska Marie, Sedlacek Radislav, ;2012;PloS one;7;e46271; 23056273
- MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function.;Brauer R, Tureckova J, Kanchev I, Khoylou M, Skarda J, Prochazka J, Spoutil F, Beck I M, Zbodakova O, Kasparek P, Korinek V, Chalupsky K, Karhu T, Herzig K-H, Hajduch M, Gregor M, Sedlacek R, ;2016;Mucosal immunology;9;974-85; 26555704
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
